133 related articles for article (PubMed ID: 1246374)
1. Treatment of adenocarcinoma of the endometrium at Memorial-James Ewing Hospitals, 1949-1965.
Homesley HD; Boronow RC; Lewis JL
Obstet Gynecol; 1976 Jan; 47(1):100-5. PubMed ID: 1246374
[TBL] [Abstract][Full Text] [Related]
2. Endometrial carcinoma: stage I. A retrospective analysis of 262 patients.
De Palo G; Kenda R; Andreola S; Luciani L; Musumeci R; Rilke F
Obstet Gynecol; 1982 Aug; 60(2):225-31. PubMed ID: 7155485
[TBL] [Abstract][Full Text] [Related]
3. Stage II endometrial adenocarcinoma. Memorial Hospital for Cancer, 1949-1965.
Homesley HD; Boronow RC; Lewis JL
Obstet Gynecol; 1977 May; 49(5):604-8. PubMed ID: 850578
[TBL] [Abstract][Full Text] [Related]
4. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
5. Prevention of vaginal recurrence of stage I endometrial adenocarcinoma with postoperative vaginal radiation.
Marchetti DL; Piver MS; Tsukada Y; Reese P
Obstet Gynecol; 1986 Mar; 67(3):399-402. PubMed ID: 3945452
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of positive peritoneal cytology in clinical stage I adenocarcinoma of the endometrium.
Lurain JR; Rumsey NK; Schink JC; Wallemark CB; Chmiel JS
Obstet Gynecol; 1989 Aug; 74(2):175-9. PubMed ID: 2748053
[TBL] [Abstract][Full Text] [Related]
7. [Treatment and prognosis of pT2 endometrial carcinoma].
Tamura H; Nakai Y; Nagano T; Ohara A; Shibamoto T; Nakayama T; Ohnishi T; Wakutani K; Taniguchi F; Suzuki N
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):315-20. PubMed ID: 2045699
[TBL] [Abstract][Full Text] [Related]
8. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
Stock RG; Chen AS; Karasek K
Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
[TBL] [Abstract][Full Text] [Related]
9. Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement.
Mariani A; Webb MJ; Keeney GL; Calori G; Podratz KC
Gynecol Oncol; 2001 Oct; 83(1):72-80. PubMed ID: 11585416
[TBL] [Abstract][Full Text] [Related]
10. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
[TBL] [Abstract][Full Text] [Related]
11. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
12. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma.
Sakuragi N; Hareyama H; Todo Y; Yamada H; Yamamoto R; Fujino T; Sagawa T; Fujimoto S
Acta Obstet Gynecol Scand; 2000 Apr; 79(4):311-6. PubMed ID: 10746848
[TBL] [Abstract][Full Text] [Related]
14. The importance of histologic grade in stage II endometrial carcinoma.
Goplerud DR; Belgrad R
Surg Gynecol Obstet; 1979 Mar; 148(3):406-8. PubMed ID: 419444
[TBL] [Abstract][Full Text] [Related]
15. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
[TBL] [Abstract][Full Text] [Related]
16. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy.
Harrison TA; Sevin BU; Koechli O; Nguyen HN; Averette HE; Penalver M; Donato DM; Nadji M
Gynecol Oncol; 1993 Sep; 50(3):310-5. PubMed ID: 8406193
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium.
Lurain JR; Rice BL; Rademaker AW; Poggensee LE; Schink JC; Miller DS
Obstet Gynecol; 1991 Jul; 78(1):63-9. PubMed ID: 2047070
[TBL] [Abstract][Full Text] [Related]
18. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
19. SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988-1994.
Cornelison TL; Trimble EL; Kosary CL
Gynecol Oncol; 1999 Sep; 74(3):350-5. PubMed ID: 10479492
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of stage I cervical adenocarcinoma treated by radical surgery.
McLellan R; Dillon MB; Woodruff JD; Heatley GJ; Fields AL; Rosenshein NB
Gynecol Oncol; 1994 Feb; 52(2):253-9. PubMed ID: 8314148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
